CMS Considers Inherent Reasonableness Rule To Lower Pay For Diabetes Test Supplies

The use of a relatively obscure CMS fee-adjustment authority rather than competitive bidding to lower Medicare payment for diabetes testing supplies in the retail setting could be precedent setting.